Lance C. Pagliaro
Impact in
- Oncology top 1%
- Cancer Immunotherapy and Biomarkers
- Pulmonary and Respiratory Medicine top 0.5%
- Prostate Cancer Treatment and Research
- Renal cell carcinoma treatment
Papers in
-
- Prostate Cancer Treatment and Research 51
- Renal cell carcinoma treatment 43
- Surgery 90
- Bladder and Urothelial Cancer Treatments 33
- Genital Health and Disease 31
- Testicular diseases and treatments 22
- Urinary and Genital Oncology Studies 19
- Co-authors
- Christopher J. Logothetis (31 shared papers)Curtis A. Pettaway (23 shared papers)Randall E. Millikan (17 shared papers)Shi‐Ming Tu (20 shared papers)Danai Daliani (13 shared papers)Nizar M. Tannir (36 shared papers)Sijin Wen (12 shared papers)Jeri Kim (10 shared papers)
- Journals
- Journal of Clinical Oncology (58 papers)The Journal of Urology (13 papers)Cancer (12 papers)Urologic Oncology Seminars and Original Investigations (10 papers)Annals of Oncology (8 papers)
- Partner nations
- United StatesSpainFrance
In The Last Decade
Lance C. Pagliaro
188 papers receiving 5.8k citations
Lance C. Pagliaro's Hit Papers
Peers
Comparison fields: 5 of 123
- Oncology 2.1k
- Pulmonary and Respiratory Medicine 2.4k
- Urology 452
- Cancer Research 1.0k
- Surgery 2.1k
Countries citing papers authored by Lance C. Pagliaro
This map shows the geographic impact of Lance C. Pagliaro's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lance C. Pagliaro with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lance C. Pagliaro more than expected).
Fields of papers citing papers by Lance C. Pagliaro
This network shows the impact of papers produced by Lance C. Pagliaro. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lance C. Pagliaro. The network helps show where Lance C. Pagliaro may publish in the future.
Co-authors
The 25 scholars most cited alongside Lance C. Pagliaro, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 199 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Treatment-Related Adverse Events of PD-1 and PD-L1 Inhibitors in Clinical Trials Hit paper breakdown → | 2019 | 594 |
| 2 | 2004 | 372 | |
| 3 | 2013 | 311 | |
| 4 | 2001 | 277 | |
| 5 | 2010 | 233 | |
| 6 | 2013 | 200 | |
| 7 | 2009 | 136 | |
| 8 | 2012 | 122 | |
| 9 | 2003 | 113 | |
| 10 | 1999 | 110 | |
| 11 | 2007 | 108 | |
| 12 | 2003 | 99 | |
| 13 | 2009 | 95 | |
| 14 | 2013 | 79 | |
| 15 | 2020 | 74 | |
| 16 | 2008 | 72 | |
| 17 | 2013 | 68 | |
| 18 | 2007 | 68 | |
| 19 | Phase II trial of alternating weekly chemohormonal therapy for patients with androgen-independent prostate cancer. | 1997 | 66 |
| 20 | 2011 | 64 |
About Lance C. Pagliaro
Lance C. Pagliaro is a scholar working on Pulmonary and Respiratory Medicine, Surgery, Oncology, Cancer Research and Molecular Biology, having authored 199 papers that have together received 5.9k indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (51 papers), Renal cell carcinoma treatment (43 papers), Bladder and Urothelial Cancer Treatments (33 papers), Genital Health and Disease (31 papers), Cancer Genomics and Diagnostics (29 papers), Urologic and reproductive health conditions (25 papers), Testicular diseases and treatments (22 papers) and Urinary and Genital Oncology Studies (19 papers). The work is most often cited by research in Oncology (2.1k citations), Pulmonary and Respiratory Medicine (2.4k citations), Urology (452 citations), Cancer Research (1.0k citations) and Surgery (2.1k citations). Lance C. Pagliaro has collaborated with scholars based in United States, Spain and France. Frequent co-authors include Christopher J. Logothetis, Curtis A. Pettaway, Randall E. Millikan, Shi‐Ming Tu, Danai Daliani, Nizar M. Tannir, Sijin Wen, Jeri Kim, Peter F. Thall and Christos N. Papandreou. Their work appears in journals such as Journal of Clinical Oncology, The Journal of Urology, Cancer, Urologic Oncology Seminars and Original Investigations and Annals of Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.